JOURNAL OF THE AMERICAN HEART ASSOCIATION, vol.8, no.6, 2019 (SCI-Expanded)
Background-There are limited data on how the combination of diabetes mellitus (DM) and chronic kidney disease (CKD) affects cardiovascular outcomes as well as response to different P2Y(12) receptor antagonists, which represented the aim of the present investigation.